Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

FDA Approves PolarityTE's Phase 3 Study Of SkinTE In Chronic Cutaneous Ulcer

FDA Grants Fast Track Tags To Drug Candidates For Antares Pharma, Celcuity, Celularity

FDA Grants Fast Track Tags To Drug Candidates For Antares Pharma, Celcuity, Celularity

34 Stocks Moving In Tuesday's Mid-Day Session

34 Stocks Moving In Tuesday's Mid-Day Session

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares gained 37.2% to $6.75 after the company eeceived FDA Breakthrough Device Designation for the treatment of chronic chemo induced peripheral neuropathy with its wearable neurostimulation technology.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

NeuroMetrix Shares Rally On FDA Breakthrough Tag For Neurostimulation Device

FDA Issues Clinical Hold On Dyne's IND For Duchenne Muscular Dystrophy Program

FDA Pushes Review Period For Bluebird bio's Neurodegenerative Disease, Thalassemia Gene Therapies

Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS

New Awakn Study Shows Ketamine Has Potential To Treat Alcoholism

inkl

Read news from The Economist, FT, and more,
with one subscription

FDA Clears Surgalign's HOLO Portal Surgical Guidance System For Spine Procedures

FDA Clears Surgalign's HOLO Portal Surgical Guidance System For Spine Procedures

Gilead Withdraws Use Of Zydelig In Two Forms Of Blood Cancer In US

Gilead Withdraws Use Of Zydelig In Two Forms Of Blood Cancer In US

Gilead Sciences Inc (NASDAQ: GILD) recently notified the FDA of its decision to

FDA Gives Back To Back Approval To Pfizer's & AbbVie's JAK Inhibitors For Atopic Dermatitis

FDA Gives Back To Back Approval To Pfizer's & AbbVie's JAK Inhibitors For Atopic Dermatitis

Along with AbbVie Inc's (NYSE: ABBV)

$FDA Approves AbbVie's Upadacitinib For Refractory Atopic Dermatitis In Patients 12 Years & Older$

FDA Approves AbbVie's Upadacitinib For Refractory Atopic Dermatitis In Patients 12 Years & Older

FDA: Medtronic slow to update, recall defective insulin pumps for diabetes patients

While the U.S. Food and Drug Administration acknowledges Medtronic is actively working on fixing issues within its diabetes business, especially in regard to some of its insulin pumps, it says the steps took too long and are not enough.

Tribune News Service

HTBX: RapidVax Unveiled; Elusys Acquisition

By John Vandermosten, CFA NASDAQ:HTBX READ THE FULL HTBX RESEARCH REPORT

What temperature should a refrigerator be? Keep your food in optimal conditions

What temperature should a refrigerator be? Keep your food in optimal conditions

Find out what temperature a refrigerator should be to keep your food safe to eat.

Get all your
news in one place.

100’s of premium titles.
One news app.

MobileHelp review

MobileHelp, a leading manufacturer of medical alert systems, offers cost savings. It collaborates with Rapid Response for call center services and focuses on innovative, compact devices.

1 … 207 208 209 210

People

John Vandermosten

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Gilead Sciences Inc

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

277,414 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play